Titan Spine reported its second quarter 2017 financial earnings.
Here are five highlights:
1. The company saw a 49 percent year-over-year growth rate at mid-year 2017.
2. nanoLOCK sales volume rose 42 percent since the end of the first quarter 2017.
3. Titan Spine reported 150 surgeons have used the nanoLOCK in 98 hospitals.
4. Surgeons have implanted 2,500 nanoLOCK implantations since its launch in 2016.
5. Surgeons have implanted more than 50,000 Endoskeleton interbody fusion devices since its launch.